Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuqiu Wan

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Human Cell|March 28, 2023
Role of ADAM33 short isoform as a tumor suppressor in the pathogenesis of thyroid cancer via oncogenic function disruption of full-length ADAM33Jing Lan, Yehui Zhou, Yang Liu, et al.
Chemosphere|November 19, 2018
Liquid phase catalytic hydrogenation reduction of Cr(VI) using highly stable and active Pd/CNT catalysts coated by N-doped carbonMinghui Li, Jiao He, Yuqiong Tang, et al.
Scientific Reports|October 21, 2016
PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancerHonggeng Guan, Yuqiu Wan, Jing Lan, et al.
Oncoimmunology|April 9, 2016
PD-L1 mediated the differentiation of tumor-infiltrating CD19<sup>+</sup> B lymphocytes and T cells in Invasive breast cancerHonggeng Guan, Yang Lan, Yuqiu Wan, et al.
Frontiers in Immunology|August 8, 2022
The interaction between the soluble programmed death ligand-1 (sPD-L1) and PD-1<sup>+</sup> regulator B cells mediates immunosuppression in triple-negative breast cancerXuejiao Li, Huan Du, Shenghua Zhan, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Human Cell|March 28, 2023
Role of ADAM33 short isoform as a tumor suppressor in the pathogenesis of thyroid cancer via oncogenic function disruption of full-length ADAM33Jing Lan, Yehui Zhou, Yang Liu, et al.
Chemosphere|November 19, 2018
Liquid phase catalytic hydrogenation reduction of Cr(VI) using highly stable and active Pd/CNT catalysts coated by N-doped carbonMinghui Li, Jiao He, Yuqiong Tang, et al.
Scientific Reports|October 21, 2016
PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancerHonggeng Guan, Yuqiu Wan, Jing Lan, et al.
Oncoimmunology|April 9, 2016
PD-L1 mediated the differentiation of tumor-infiltrating CD19<sup>+</sup> B lymphocytes and T cells in Invasive breast cancerHonggeng Guan, Yang Lan, Yuqiu Wan, et al.
Frontiers in Immunology|August 8, 2022
The interaction between the soluble programmed death ligand-1 (sPD-L1) and PD-1<sup>+</sup> regulator B cells mediates immunosuppression in triple-negative breast cancerXuejiao Li, Huan Du, Shenghua Zhan, et al.
Pageof 2